Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.

Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.

The American Journal of Cardiovascular Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

There are no publication charges for standard publishing in theAmerican Journal of Cardiovascular Drugs; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €3,060 / US$3,860). Please click on the link below under ‘Publishing model’ for further information about this service.

Journal information

Editor
  • Amitabh Prakash
Publishing model
Hybrid. Open Access options available

Journal metrics

2.578 (2018)
Impact factor
2.282 (2018)
Five year impact factor
28 days
Submission to first decision
122 days
Submission to acceptance
76,179 (2019)
Downloads

Latest articles

This journal has 51 open access articles

Societies, partners and affiliations

  • International Academy of Cardiovascular Sciences
    International Academy of Cardiovascular Sciences

About this journal

Electronic ISSN
1179-187X
Print ISSN
1175-3277
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/Clinical Medicine
  4. EBSCO Academic Search
  5. EBSCO CINAHL
  6. EBSCO Discovery Service
  7. EBSCO STM Source
  8. EMBASE
  9. Google Scholar
  10. Institute of Scientific and Technical Information of China
  11. Japanese Science and Technology Agency (JST)
  12. Journal Citation Reports/Science Edition
  13. Medline
  14. Naver
  15. OCLC WorldCat Discovery Service
  16. Pathway Studio
  17. ProQuest Central
  18. ProQuest Health & Medical Collection
  19. ProQuest Health Research Premium Collection
  20. ProQuest Medical Database
  21. ProQuest-ExLibris Primo
  22. ProQuest-ExLibris Summon
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index
  27. Science Citation Index Expanded (SciSearch)
  28. Semantic Scholar
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG